SGLT2 inhibitors have many beneficial effects in humans, and we need to further explore the association and association mechanism between SGLT2 inhibitors and ALS through basic and clinical studies and explore the possibility of SGLT2 inhibitors as potential therapeutic targets for ALS. This evidence concerns the gene SLC5A2 and amyotrophic lateral sclerosis.